About

Bio

FiercePharmaAsia is an industry newsletter covering news and analysis on the Asia Pacific biopharma industry including new deals, collaborations, advances and setbacks on clinical trials, biopharma regulatory challenges and approvals and rejections of new drug applications, Biopharma Company News, Pharma Marketing and Sales, Patent Expirations, Drug Development, Mergers and Acquisitions and more.

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United States of America

Frequency

upgrade

Circulation

upgrade

Sectors

Pharmaceutical Manufacturers, Pharmaceuticals, American Samoa, Australia, Bangladesh, Bhutan, Brunei, Cambodia, China, Cocos Islands, Cook Islands, Fiji, French Polynesia, Guam, Hong Kong, India, Indonesia, Japan, Kiribati, Laos, Macau, Malaysia, Maldives, Marshall Islands, Micronesia, Myanmar, Nauru, Nepal, New Caledonia, New Zealand, Niue, Norfolk Island, North Korea, Northern Mariana Islands, Pakistan, Palau, Papua New Guinea, Philippines, Samoa, Singapore, Solomon Islands, South Korea, Sri Lanka, Taiwan, Thailand, Timor-Leste, Tokelau, Tonga, Tuvalu, Vanuatu, Vietnam, Wallis & Futuna


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by FiercePharmaAsia

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to FiercePharmaAsia

  • STAT News
    STAT News

    Covers the frontiers of health and medicine including science labs, hospitals, biotechnology board rooms, and political back rooms. Hosted by The Boston Globe, STAT launched on November 5, 2015.

    View
  • M
    Medscape

    Medscape was created for medical specialists, primary care physicians, and health professionals and offers medical news, clinical trial information, review articles, journal commentary, expert columns, patient education articles and book reviews. It also includes Web-based services for verifying insurance information, Medline and other search engines, as well as a physician directory enabling users to find physicians by practice, location or specialty. It offers conference coverage through leaders summarizing key data and presentations from major medical meetings; The Medscape Journal of Medicine, the Internet's first medical journal; MedPulse, a weekly e-mail newsletter; and business, financial, managed care and medical practice information. Some of Medscape's key features include: -Original, professional medical content, including review articles, journal commentary, expert columns, patient education articles and book reviews -More than 850 online CME activities; -Conference Coverage: Thought leaders summarize key data and presentations from major medical meetings; -The Internet's first primary-source medical journal, The Medscape Journal of Medicine; -Selected daily professional medical news in various specialties from Reuters, Medscape Medical News, and medical news journal publishers -Physician Optimized MEDLINE -Free subscription to Medscape's MedPulse, a weekly email newsletter that highlights what's new in various specialties -More than 125 medical journals and textbooks -Business, financial, managed care, and medical practice information The outlet offers RSS (Really Simple Syndication).

    View
  • Sunday Mail
    Sunday Mail

    Background and Format: A weekly publication covering news, sport, features and weather for the whole of Scotland, and Belfast. It is published in 5 editions, North, East and West Scotland, Waterfrod and Belfast. Audience and Readership: The newspaper is aimed at people living in North, East and West Scotland, Waterford and Belfast. Circulation: Source: ABC Distribution: The newspaper is available through subscription and at regional newsstands. Ad Rates: For information on ad rates fill out the form Normal 0 false false false EN-GB X-NONE X-NONE MicrosoftInternetExplorer4 here. <w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideW

    View
  • The Conversation UK
    The Conversation UK

    Background and Format: The Conversation is an independent source of news and views, sourced from the academic and research community. The team of editors work with university and research institute experts. The aim is to allow for better understanding of current affairs and complex issues and hopefully allow for a better quality of public discourse and conversations.The Conversation launched in Australia in March 2011 and was launched in the UK in 2013. The Conversation UK is a distinct site, focused on issues of relevance to a local audience. The UK version is funded by City University, the Australian version is funded by the Government. Audience and Readership: The Conversation is aimed at everyone interested in current affairs. Deadline: Ongoing. Stories usually posted at 8am, 11am and 3pm Monthly Unique Users: They do not disclose their Monthly Unique User figures. Supplements and sections: Arts Culture Business & Economy Education Environment & Energy Health & Medicine Politics & Society Science & Technology Ad Rates: Advertising information are not disclosed. Other information: The Conversation only publishes articles written by academics on topics of their expertise related to events in the news. Authors’ funding and potential conflicts of interest must also be disclosed. They do not cover new product launches, new companies or news events, and do not publish the thoughts of or quotes from business people.  To pitch an idea, use this page here. Awards: 2017 - Scottish Press Awards, Digital Team of the Year: Brexit Fact Check (nominated) 2016 - British Journalism Awards, Digital Innovation (nominated)

    View
  • E
    Endpoints News

    Endpoints News covers Biopharmaceutical industry. Offers the latest data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).

    View
Use CisionOne to find more relevant outlets

Contact FiercePharmaAsia and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.